NewsRx

Search our medical news database

Breast Cancer (Screening)

p43 Blood Test Can Detect Early Stage Cancer

Published in Cancer Weekly, August 5th, 1996

Oncor, Inc., Gaithersburg, Maryland, announced that it has obtained an exclusive, worldwide license for a blood test capable of detecting early-stage breast cancer.

After U.S. Food and Drug Administration (FDA) approval, Oncor has planned to market the blood test as a companion to conventional mammograms of women at high risk for the disease. "The p43 test detects an early immunological event in the body's response to the development of primary breast cancer that can be measured in patient blood, particularly with respect to women at high risk for breast cancer," said Chaya Moroz, Ph.D., Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook